Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC)
2014-005610-37Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of avatrombopag in endometrial cancer (EC) and endometrial hyperplasia (EH), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Ki-67 expression in the endometrium. Started Mar 2015; status: completed.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)endometrial hyperplasia (EH)
Beyond the preview
Go deeper on 2014-005610-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005610-37.